期刊文献+

子母导管行血栓抽吸在急性心肌梗死患者急诊介入治疗中的临床应用价值

下载PDF
导出
摘要 目的:评估子母导管在急性心肌梗死治疗中的临床应用价值。方法:将120例行急诊介入治疗的急性心肌梗死患者随机分为两组,其中使用子母导管行血栓抽吸65例患者作为子母导管组,未行血栓抽吸常规球囊预扩张后植入支架55例患者作为对照组。比较两组间基础临床特征、置入支架术后无复流发生率、术后ST段下降率以及血栓抽吸后需球囊预扩张的比例。结果:子母导管组2例发生无复流,发生率3.1%;对照组8例发生无复流,发生率14.5%。两组住院期间均无心脏不良事件发生。子母导管组患者的无复流发生率和血栓抽吸后需球囊预扩张后置入支架的比例明显低于常规治疗组,两组差异有统计学意义(P﹤0.05)。结论:急性心肌梗死在急诊介入治疗中,应用子母导管行血栓抽吸是安全有效的,能有效清除冠状动脉内新鲜血栓,可以明显降低支架置入术后无复流发生率,减少预扩张球囊的使用。
出处 《山西职工医学院学报》 CAS 2013年第6期14-16,共3页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献6

  • 1王乐丰,张大鹏.急性心肌梗死急诊再灌注治疗后心肌组织无复流的防治[J].临床内科杂志,2007,24(1):11-13. 被引量:5
  • 2Resnic FS, WainsteinM, Lee MK, et al. No-reflow is an Independ En- tpredietor of Death and Myocardial Infarction after Percutaneous Coro- naiy Intervention [ J ] . AmHeart J,2003,145 ( 1 ) :42-46.
  • 3Kelbaek H,Terkelsen C J, Helqvist S,et al. Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutane- ous Coronary Intervention:the Drug Elution and Distal Protection in ST-elevation Myocardial Infarction ( DEDICATION ) Trial [ J ]. J Am Coil Cardiol,2008,51 (7) 899-905.
  • 4Smith SC, Fdldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAIWriting Committee to Update the 2001 Guidelines for Percutaneous Cornary Intrevertion ) [ J]. J Am Coil Cardiol,2006,47( 1 ) :117-121.
  • 5Reffelmanntklonerra. The No-reflow Phenomenon : A Basic Mechanism of Myocardial is Chemia and Reperfusion [ J ]. Basic Res Cardiol, 2006,101:359-372.
  • 6Ali A, Cox D, Dib N,et al. Rheolytic Thrombectomy with Percutaneous Coronary Interverntion for Infarct Size Traduction in Acute Myocardial Infarction 30-dau Results from a Muticemter Ramdomized Study [ J ]. J Am Coil Cardio1,2006 ,g8 (2) :244-252.

二级参考文献21

  • 1Kunichika H,Ben-Yehuda O,Lafitte S,et al.Effects of glycoprotein Ⅱb/Ⅲa inhibition on microvascular flow after coronary reperfusion.A quantitative myocardial contrast echocardiography study.J Am Coll Cardiol,2004,43:276-283.
  • 2Zeymer U,Schroder K,Wegscheider K,et al.ST resolution in a single electrocardiographic lead:a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction.Am Heart J,2005,149:91-97.
  • 3Greaves K,Dixon S R,Fejka M,et al.Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction.Heart,2003,89:139-144.
  • 4Antoniucoi D,Rodriguez A,Hempel A,et al.A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.J Am Coll Cardiol,2003,42:1879-1885.
  • 5Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glyooprotein Ⅱb/Ⅲa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes:results of the Tirofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
  • 6Leonardo Bolognese,Giovanni Falsini,Francesco Liistro,et al.Randomized Comparison of Upstream Tirofiban Versus Downstream High Bolus Dose Tirofiban or Abciximab on Tissue-Level Perfusion and Troponin Release in High-Risk Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions.The EVEREST Trial.J Am Coll Cardiol,2006,47:522-528.
  • 7Eve D.Aymong,Michael J.Curtis,Mostafa Youssef,et al.Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting.Circulation,2002,105:2981-2985.
  • 8Jochen W(o)hrle,Olaf C.Grebe,Thorsten Nusser,et al.Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty.Circulation,2003,107:1840-1843.
  • 9Teng-Yao YANG,Shi-Tai CHANG,Chang-Ming CHUNG,et al.Restoration of Normal Coronary Flow With Tirofiban by Intracoronary Administration for No-reflow Phenomenon After Stent Deployment.Int Heart J,2005,46:139-145.
  • 10Satoshi Ota,Hidee Nishikawa,Masaki Takeuchi,et al.Impact of Nicorandil to Prevent Repeffusion Injury in Patients With Acute Myocardial Infarction-Sigmart Multicenter Angioplasty Revascularization Trial(SMART).Circ J,2006,70:1099-1104.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部